RxDoctor Payments Data

Anna Koch, PA

Physician Assistant · Dunn, NCNPI 1730889577

Payments from drug & device makers

$1,052in general payments, 2019–2025

Across 52 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$227
  • Amgen$151
  • Pfizer$146
  • AbbVie$125
  • Exact Sciences$92
  • Boehringer Ingelheim$87
  • plus $223 from 7 others

What the payments were for

  • Food & beverage$1,052100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,052 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$86,338
Medicare patients
171
Services billed
1,724

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide37$52,763
EliquisApixaban60$52,560
JardianceEmpagliflozin30$30,551
TrulicityDulaglutide16$18,964
RybelsusSemaglutide14$15,106
Spiriva HandihalerTiotropium Bromide11$7,218
SynthroidLevothyroxine Sodium63$5,202
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$3,134
Albuterol Sulfate HfaAlbuterol Sulfate79$2,502
Gabapentin159$2,283
Fluticasone Propionate56$2,204
Diclofenac Sodium28$1,837
Metoprolol Succinate118$1,735
Atorvastatin Calcium240$1,719
Levothyroxine Sodium180$1,476

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$227$67,86951 claims
PfizerEliquis$146$52,56060 claims
Boehringer IngelheimJardiance$87$30,55130 claims
Lilly USA, LLCTrulicity$53$18,96416 claims
AbbVieSynthroid$125$5,20263 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Dunn

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →